Wenxiao Jiang

1.1k total citations
29 papers, 819 citations indexed

About

Wenxiao Jiang is a scholar working on Molecular Biology, Obstetrics and Gynecology and Cancer Research. According to data from OpenAlex, Wenxiao Jiang has authored 29 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Obstetrics and Gynecology and 6 papers in Cancer Research. Recurrent topics in Wenxiao Jiang's work include Cancer-related molecular mechanisms research (6 papers), Uterine Myomas and Treatments (4 papers) and Ubiquitin and proteasome pathways (3 papers). Wenxiao Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Uterine Myomas and Treatments (4 papers) and Ubiquitin and proteasome pathways (3 papers). Wenxiao Jiang collaborates with scholars based in China, United States and Israel. Wenxiao Jiang's co-authors include Xueqiong Zhu, Shuya Pan, Zhiwei Wang, Xin Chen, Yichi Xu, Shangdan Xie, Qi Shen, Fang Xue, Yehuda G. Assaraf and Ruanmin Zou and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Fertility and Sterility.

In The Last Decade

Wenxiao Jiang

28 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenxiao Jiang China 16 463 281 173 120 119 29 819
Xiao Sun China 16 398 0.9× 240 0.9× 145 0.8× 79 0.7× 65 0.5× 40 795
Wanrun Lin United States 14 388 0.8× 296 1.1× 156 0.9× 82 0.7× 162 1.4× 33 802
Bastian Czogalla Germany 15 237 0.5× 103 0.4× 176 1.0× 54 0.5× 40 0.3× 64 620
Jianming Huang China 13 211 0.5× 128 0.5× 106 0.6× 36 0.3× 34 0.3× 41 450
Yibing Fu China 13 372 0.8× 274 1.0× 76 0.4× 42 0.3× 54 0.5× 20 598
Xiangyu Zhou China 13 299 0.6× 120 0.4× 67 0.4× 61 0.5× 56 0.5× 43 638
Sivakumar Ramadoss United States 12 478 1.0× 173 0.6× 189 1.1× 51 0.4× 67 0.6× 16 793
Xiangrong Cui China 16 383 0.8× 196 0.7× 126 0.7× 66 0.6× 12 0.1× 43 745
Elisabeth Smolle Austria 12 329 0.7× 237 0.8× 146 0.8× 154 1.3× 21 0.2× 21 639
Wenyan Wang China 16 232 0.5× 177 0.6× 90 0.5× 41 0.3× 68 0.6× 44 541

Countries citing papers authored by Wenxiao Jiang

Since Specialization
Citations

This map shows the geographic impact of Wenxiao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxiao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxiao Jiang more than expected).

Fields of papers citing papers by Wenxiao Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenxiao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxiao Jiang. The network helps show where Wenxiao Jiang may publish in the future.

Co-authorship network of co-authors of Wenxiao Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenxiao Jiang. A scholar is included among the top collaborators of Wenxiao Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenxiao Jiang. Wenxiao Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pan, Shuya, Wenxiao Jiang, Shangdan Xie, Haiyan Zhu, & Xueqiong Zhu. (2021). Clinicopathological Features and Survival of Adolescent and Young Adults with Cervical Cancer. Cancer Control. 28. 2895469606–2895469606. 10 indexed citations
3.
Liu, Yi, Yichi Xu, Wenxiao Jiang, et al.. (2021). Discovery of key genes as novel biomarkers specifically associated with HPV-negative cervical cancer. Molecular Therapy — Methods & Clinical Development. 21. 492–506. 22 indexed citations
4.
Jiang, Wenxiao, et al.. (2021). Overexpression of Galectin10 Predicts a Better Prognosis in Human Ovarian Cancer. Journal of Cancer. 12(9). 2654–2664. 3 indexed citations
5.
Jiang, Wenxiao, Shuya Pan, Xin Chen, Zhiwei Wang, & Xueqiong Zhu. (2021). The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy. Molecular Cancer. 20(1). 116–116. 119 indexed citations
6.
Jiang, Wenxiao, Yichi Xu, Xin Chen, Shuya Pan, & Xueqiong Zhu. (2021). E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms. Molecular Therapy — Oncolytics. 22. 518–527. 15 indexed citations
7.
Zhou, Junhan, Wenxiao Jiang, Wenbin Huang, Miaomiao Ye, & Xueqiong Zhu. (2020). Prognostic Values of Transforming Growth Factor‐Beta Subtypes in Ovarian Cancer. BioMed Research International. 2020(1). 2170606–2170606. 11 indexed citations
8.
Xu, Yichi, Shuya Pan, Wenxiao Jiang, Fang Xue, & Xueqiong Zhu. (2020). Effects of propofol on the development of cancer in humans. Cell Proliferation. 53(8). e12867–e12867. 75 indexed citations
9.
Xu, Yichi, Wenxiao Jiang, Shangdan Xie, Fang Xue, & Xueqiong Zhu. (2020). <p>The Role of Inhaled Anesthetics in Tumorigenesis and Tumor Immunity</p>. Cancer Management and Research. Volume 12. 1601–1609. 19 indexed citations
10.
Wang, Peter, Xiaoming Dai, Wenxiao Jiang, Yuyun Li, & Wenyi Wei. (2020). RBR E3 ubiquitin ligases in tumorigenesis. Seminars in Cancer Biology. 67(Pt 2). 131–144. 71 indexed citations
11.
Jiang, Wenxiao, Shangdan Xie, Yi Liu, Shuangwei Zou, & Xueqiong Zhu. (2020). The Application of Patient-Derived Xenograft Models in Gynecologic Cancers. Journal of Cancer. 11(18). 5478–5489. 9 indexed citations
12.
Jiang, Wenxiao, Min Lin, & Zhiwei Wang. (2020). Dioscin: A new potential inhibitor of Skp2 for cancer therapy. EBioMedicine. 51. 102593–102593. 17 indexed citations
13.
Shen, Qi, et al.. (2016). Differential Expression of Aquaporins in Cervical Precursor Lesions and Invasive Cervical Cancer. Reproductive Sciences. 23(11). 1551–1558. 16 indexed citations
14.
Jiang, Wenxiao, et al.. (2016). Comparison of polyvinyl alcohol and tris-acryl gelatin microsphere materials in embolization for symptomatic leiomyomas: a systematic review. Minimally Invasive Therapy & Allied Technologies. 25(6). 289–300. 9 indexed citations
15.
Jiang, Wenxiao, Qi Shen, Miaomiao Chen, et al.. (2014). Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: A systematic review. Steroids. 86. 69–78. 26 indexed citations
16.
Zhu, Xuejie, Shuangwei Zou, Qi Shen, et al.. (2013). Immunohistochemical Expression of RAGE and Its Ligand (S100A9) in Cervical Lesions. Cell Biochemistry and Biophysics. 66(3). 843–850. 22 indexed citations
17.
Zou, Shuangwei, Qi Shen, Ying Hua, et al.. (2013). Proteomic Identification of Neoadjuvant Chemotherapy-Related Proteins in Bulky Stage IB-IIA Squamous Cervical Cancer. Reproductive Sciences. 20(11). 1356–1364. 11 indexed citations
18.
Shen, Qi, Ying Hua, Wenxiao Jiang, et al.. (2013). Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis. Fertility and Sterility. 100(6). 1722–1726.e10. 59 indexed citations
19.
Jiang, Shanshan, et al.. (2012). Expression and Localization of Aquaporins 8 and 9 in Term Placenta With Oligohydramnios. Reproductive Sciences. 19(12). 1276–1284. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026